At Stilla Technologies, we’re pushing boundaries of digital PCR, transforming complex genomic data into clear, actionable insights that drive breakthroughs in cancer research, liquid biopsy, cell and gene therapies, infectious disease detection, and more.

Cell-Easy is a Cell Therapy specialized CDMO. They support biotechs, Pharmas & public institutions in their GMP Development & Manufacturing. Their mission: Accelerate your Cell Therapy’s path to market, keeping patient access at the center.

Each month, MabDesign's market analyses give you an overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market for biomedicines and biomanufacturing. This month, an overview of antibody-oligonucleotide conjugate (AOC) projects currently in development.

L'analyse marché MabDesign de ce mois-ci vous donne un aperçu du marché et des projets de conjugués anticorps-oligonucléotides actuellement en développement.